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DObjective: The study objective was to evaluate the safety and efficacy of concomitant bipolar radiofrequency
ablation and heart valve replacement in patients with rheumatic heart disease and atrial fibrillation.
Methods: A total of 191 patients with rheumatic heart disease and chronic atrial fibrillation underwent valve
replacement with concomitant bipolar radiofrequency ablation. There were 78 male and 113 female patients
with a mean age of 46.0 9.1 years and an atrial fibrillation duration of 43.7 15.4 months. Valve replacement
surgery included mitral valve replacement in 121 patients, mitral and aortic valve replacement in 59 patients,
mitral and tricuspid valve replacement in 8 patients, and triple valve replacement in 3 patients. All patients re-
ceived oral antiarrhythmic drugs for 3 to 6 months postoperatively. Follow-up electrocardiography and color
Doppler echocardiography were performed postoperatively.
Results: The mean aortic crossclamping time was 84.0  25.5 minutes, and cardiopulmonary bypass time was
139.4  39.1 minutes. There was no abnormal bleeding due to bipolar radiofrequency ablation. Three patients
(1.57%) died of low cardiac output syndrome in hospital at 2, 3, and 5 days after surgery. Major perioperative
complications include reoperation for bleeding (n ¼ 1), reoperation for wound infection (n ¼ 1), intra-aortic
balloon pump placement (n ¼ 2), and renal failure (n ¼ 2). All other patients were discharged without compli-
cations. The mean follow-up time was 17.4 11.8 months with a follow-up rate of 95.3%. There were no cases
of late death, complete atrioventricular block, or anticoagulation-induced complications. Of 158 patients who
were followed up for 1 year, sinus rhythm was maintained in 125 (79.11%).
Conclusions: Concomitant bipolar radiofrequency ablation is an effective and safe technique for treating atrial
fibrillation in patients with rheumatic heart disease undergoing valve replacement, with promising follow-up re-
sults. (J Thorac Cardiovasc Surg 2013;145:1013-7)Atrial fibrillation (AF) is the most common dysrhythmia en-
countered in clinical practice,1 with an overall prevalence of
0.77% in China and a prevalence of 45% to 60% among
those with rheumatic heart disease.2 AF has high morbidity
and mortality rates, including complications such as stroke
and heart failure, which affect patient quality of life. Sur-
gery is the most effective treatment option for AF.3 The
Cox Maze III procedure is regarded as the gold standard
for the treatment of AF,4,5 but it is complicated, time-
consuming, and traumatic, which limit its clinical useful-
ness. Many improved Maze procedures have therefore
been proposed, among which bipolar radiofrequency abla-
tion (BRFA) is currently of interest. In the current study,e Departments of Cardiac Surgerya and Oncology,b West China Hospital,
an University, Chengdu, China.
ures: Authors have nothing to disclose with regard to commercial support.
he co-first author.
d for publication Dec 28, 2011; revisions received March 26, 2012; accepted
blication May 7, 2012; available ahead of print June 7, 2012.
for reprints: Li Ren, MD, Department of Oncology, West China Hospital,
an University, No 37, Guoxue Alley, Chengdu 610041, China (E-mail:
x@163.com or doctorfu510@163.com).
23/$36.00
Copyright  2013 Published by Elsevier Inc. on behalf of The American
tion for Thoracic Surgery
016/j.jtcvs.2012.05.009
The Journal of Thoracic and Carour prospective data were reviewed to evaluate the predic-
tors in 191 consecutive patients who underwent BRFA
with valve replacement from January 2009 to June 2011.2MATERIALS AND METHODS
Clinical Data
The present study included 78male and 113 female patients with amean
age ( standard deviation) of 46.0 9.1 years (range, 20-66 years). AFwas
defined as paroxysmal, persistent, or long-standing persistent per recent
guidelines.6 The median duration of AF was 43.7  15.4 months (6-120
months). All of the patients had persistent or long-standing persistent
AF. There was no history of embolism in any of the patients. Major comor-
bidities include coronary heart disease (n¼ 0), chronic obstructive pulmo-
nary disease (n ¼ 5), and diabetes (n ¼ 2). Valvular diseases included
rheumatic valve disease in 175 patients and degenerative valve diseases
in 16 patients. According to the New York Heart Association functional
classification system, 48 patients were graded as class II, 131 patients
were graded as class III, and 12 patients were graded as class IV. Preoper-
ative color Doppler echocardiography demonstrated a mean left atrial di-
ameter of 36 to 109 mm (56.7  11.3 mm), left ventricular end-diastolic
diameter of 33 to 80 mm (49.8 8.1 mm), left ventricular ejection fraction
of 35% to 72% (57.3%  6.6%), and left atrial thrombus in 41 patients.
Preoperative standard 12-lead electrocardiography (ECG) showedAF in all
patients.
Surgery included mitral valve replacement in 121 patients, double mi-
tral and aortic valve replacement in 59 patients, double mitral and tricuspid
valve replacement in 8 patients, and triple valve replacement in 3 patients.
Imported St Jude Medical, Inc (St Paul, Minn ) bileaflet mechanical valvesdiovascular Surgery c Volume 145, Number 4 1013
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AF ¼ atrial fibrillation
BRFA ¼ bipolar radiofrequency ablation
ECG ¼ electrocardiography
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patients. Concomitant tricuspid valvuloplasty, left atrial thrombectomy,
and left atrial plication were performed in 69, 59, and 13 patients,
respectively.
Late recurrence was defined as any episode of AF, atrial flutter, or atrial
tachycardia that lasted more than 30 seconds. Patients were only consid-
ered to be a success if they were not taking antiarrhythmic drugs and
were free of atrial tachyarrhythmias.7
The medical ethical committee of West China Hospital approved the
study. Informed consent and permission for release of information were ob-
tained from each participant.
Surgical Procedures
All surgery was performed under general anesthesia with moderate hy-
pothermia and moderate hemodilution. An AtriCure Bipolar System (iso-
lators and GlidePath tape; AtriCure Inc, Cincinnati, Ohio) was used for
BRFA, according to the following protocol. All lesions were performed
with the BRFA device. After induction of general anesthesia, an esophageal
echocardiography probe was placed to evaluate valve pathology, cardiac
function, and left atrial thrombus. The patient was then heparinized. If there
was no left atrial thrombus, the right pulmonary vein was isolated and a cir-
cular ablation line was performed on the beating heart before aortic cross-
clamping. After aortic crossclamping, the right pulmonary vein and left
atrial appendage were isolated and the ligament of Marshall was cut.8
The left atrium was entered via the right atrium through the interatrial sep-
tum. Ablation lines were created between the left atrial appendage and the
left superior pulmonary vein, between the bilateral superior and inferior
pulmonary veins, between the right inferior pulmonary vein and the left su-
perior pulmonary vein, and between the posterior leaflets of the mitral
valve. If therewas left atrial thrombus, aortic crossclamping was performed
first followed by atrial thrombectomy with care to avoid coronary artery
damage, before isolation of the pulmonary vein and left atrium. The left
atrial appendagewas then sutured closed from the internal aspect, followed
by valve replacement surgery. The interatrial septum was sutured closed,
and an ablation linewas created in thewall of the right atrium from the right
atrial incision to the inferior vena cava and the anterior leaflet of the tricus-
pid valve (Figure 1).9 Ablation lines should all be ablated at least 4 times,FIGURE 1. Cox maze lesion set made with IBRF device. SVC, Superior
vena cava; IVC, inferior vena cava.
1014 The Journal of Thoracic and Cardiovascular Surand the circular ablation line around the pulmonary veins should be ablated
at least 5 times. Valve function was assessed by transesophageal echocar-
diography, and temporary cardiac pacing wires were placed.
Postoperative Care
All patients received a postoperative amiodarone infusion (0.5-1.5 mg/
kg/h) to maintain the heart rate at 60 to 140 beats/min after weaning from
cardiopulmonary bypass. After the patients were discharged from the in-
tensive care unit, the drug was administered orally, starting at 200 mg/d
once or twice daily, for 3 to 6 months and then adjusted according to the
heart rate, because early postoperative arrhythmias may be caused by
mechanisms other than persistent or long-standing persistent AF. If patients
were in sinus rhythm at 3 months, the antiarrhythmic drugs were discontin-
ued (n ¼ 148). If patients failed to maintain sinus rhythm at 3 to 6 months,
we resumed antiarrhythmic treatment and attempted electrical cardiover-
sion if required (n¼ 34).10 For the purpose of this analysis, we defined an-
tiarrhythmic drugs as class I or III. Beta-blockers or calcium channel
blockers were not considered to be antiarrhythmic drugs.7Warfarin was ad-
ministered orally for 48 hours after surgery to maintain the international
normalized ratio at 1.5 to 2.0.11
Follow-up
All data were obtained for each patient during the postoperative period.
The clinical examination and a 12-lead ECG were obtained at each visit,
and an echocardiography analysis was performed after 3, 6, and 12 months.
In all patients, oral anticoagulation was maintained and discontinued in the
patients undergoing valve repair or replacement with bioprostheses who
were in sinus rhythm within 3 months postoperatively.12
Statistic Analysis
Statistical analysis was performed using SPSS software version 18
(SPSS Inc, Chicago, Ill). All data are expressed as the mean standard de-
viation. Quantitative data were compared using the Student t test. Multiple
logistic regression analysis with forward selection, backward elimination,
and stepwise regressionmethodswas used to analyze relationships between
variables and surgical outcomes. Levels of statistical significancewere set at
significance level of entry ¼ 0.30 and significance level of staying ¼ 0.05.
RESULTS
Aortic crossclamping time was 81.3  31.2 minutes (49-
155 minutes), and cardiopulmonary bypass time was
139.4 39.1 minutes (61-224 minutes). The additional aor-
tic crossclamping time required for the radiofrequency ab-
lation was 21.9  3.7 minutes (13-32 minutes). Three
patients died of low cardiac output syndrome at 2, 3, and
5 days after surgery. Major perioperative complications in-
clude reoperation for bleeding (n ¼ 1), reoperation for
wound infection (n ¼ 1), intra-aortic balloon pump place-
ment (n ¼ 2), and renal failure (n ¼ 2). All other patients
were discharged without complications such as endocardi-
tis, pneumonia, stroke, prolonged ventilation, and perma-
nent pacemaker. Follow-up was successfully undertaken
in 182 patients (95.3%) with a follow-up time of 2 to 29
months (17.4 11.8 months). Of 158 patients whowere fol-
lowed up for 1 year after surgery, 125 (79.11%) had normal
sinus rhythm confirmed by ECG and echocardiography
(atrial Awave) (Table 1). There were no cases of late death,
complete atrioventricular block, or anticoagulation-induced
complications, such as hemorrhage and thromboembolismgery c April 2013
TABLE 1. Postoperative cardiac rhythm of 182 patients
Time Sinus rhythm Nodal rhythm
AF/atrial flutter/atrial
tachycardia
Day of surgery 82.97% (151/182) 4.95% (9/182) 12.09% (22/182)
Day of discharge 72.53% (132/182) 0 (0/182) 13.74% (25/182)
3 mo after surgery 81.32% (148/182) 0 (0/182) 18.68% (34/182)
6 mo after surgery 80.22% (146/182) 0 (0/182) 19.78% (36/182)
1 y after surgery 79.11% (125/158) 4.43% (7/158) 16.45% (26/158)
AF, Atrial fibrillation.
Dong et al Acquired Cardiovascular Disease
A
C
Dduring the follow-up period. Echocardiography showed re-
duced left atrial and ventricular diameters and increased left
ventricular ejection fraction compared with preoperative
values. The results are shown in Table 2.
Multiple logistic regression analysis was used to analyze
the effects of age, duration of AF, preoperative atrial and
ventricular diameters, left ventricular ejection fraction, aor-
tic crossclamping time, cardiopulmonary bypass time, and
BRFA time on surgical outcomes.13,14 Our results showed
significant associations between the duration of AF and
preoperative left atrial diameter and surgical outcome
(P<.01). No significant associations were found between
other variables and surgical outcome (Table 3).DISCUSSION
AF is the most common sustained arrhythmia encoun-
tered in clinical practice. This arrhythmia results in irregu-
lar atrial electrical activity and loss of atrial contraction. AF
may be caused bymultiple mechanisms.Most ectopic excit-
atory foci are located in the pulmonary veins, particularly in
the superior pulmonary veins. AF results from the combina-
tion of multiple wavelets induced by ectopic atrial excita-
tion and reentry pathways. AF has 3 main consequences:
(1) patient anxiety due to irregular palpitations; (2) loss of
coordinated atrioventricular contraction resulting in
a 30% reduction in cardiac output, and eventual congestive
heart failure; and (3) blood stasis in the left atrium, which
may result in thrombosis and embolism. Because the mor-
tality rate in patients with AF is doubled compared with pa-
tients without AF, treatment is important.6 Surgery is the
most effective treatment for AF, with the Cox Maze III pro-
cedure considered the gold standard with a 99% success
rate. During the Cox Maze III procedure, multiple linearTABLE 2. Atrial and ventricular diameters before and after surgery
Measurement
Before surgery
(mm)
After surgery
(mm)
Left atrial diameter 56.7  11.4 45.8  8.4*
Left ventricular diameter 49.9  8.2 45.8  5.6*
Left ventricular ejection fraction 57.3  6.7 59.4  6.0*
*Student t test for paired quantitative data. P< .01, mean  standard deviation,
n ¼ 158.
The Journal of Thoracic and Carcuts are made to isolate the atrium from the pulmonary
veins and reduce connections between atrial tissues,
so that the reentry of multiple wavelets is blocked and
the heart can revert to normal sinus rhythm and regular
atrioventricular contraction. However, the Cox Maze III
procedure is a complicated and time-consuming operation
causing significant trauma and complications,15 including
a high rate of postoperative bleeding and sick sinus syn-
drome, which limits its usefulness. Recent techniques
have combined the Maze operation with other procedures,
including radiofrequency ablation, microwave ablation,
cryoablation, and laser ablation, among which radiofre-
quency ablation is the most commonly used.16
Radiofrequency ablation uses the hyperthermic effects of
radiofrequency current and its ability to penetrate tissues to
induce transmuralmyocardial injury by coagulation necrosis
to block the reentry loops that cause and maintain AF. The
radiofrequency electrodes can be unipolar or bipolar. The
unipolar electrode is easier tomovearoundbut requires a lon-
ger time for coagulation and is more difficult to target pre-
cisely. It is more difficult to judge if transmural ablation is
completewith a unilateral electrode, and it is easy to damage
adjacent tissues (especially the esophagus and pulmonary
veins). BRFA is gradually being introduced into clinical
practice. The AtriCure bipolar radiofrequency device used
in the present study is a clamp that places the negative and
positive electrodes on either side of the targeted tissues to
precisely focus the energy. The device has an intelligent
and fast-acting feedback system and creates a tidy ablation
line with clear boundaries, which ensures good penetration
and avoids indirect damage to surrounding tissues.17
Of the 182 patients who were followed up, 79.11% were
maintaining normal sinus rhythm at 1 year postoperatively
as verified by ECG and color Doppler echocardiography.
Furthermore, there was a significant reduction in left atrial
diameter and recovery of left atrial contraction in patients
whomaintained sinus rhythm postoperatively, which is con-
sistent with previous reports.18-20 Considering the results of
the present study, we propose the following: (1) AF ablation
lesions should be closely interconnected, particularly in
areas that may have multiple accessory pathways, such as
the atrioventricular ring and the openings of the large
vessels. This will increase the success rate of blockingdiovascular Surgery c Volume 145, Number 4 1015
TABLE 3. Results of logistic regression analysis showing associations between duration of atrial fibrillation and preoperative left atrial diameter
and surgical outcome
Variable Standard error Regression coefficient Odds ratio Wald chi-square P 95% CI
AF time (wk) 0.0217 0.0846 0.919 15.18 <.001 0.881-0.959
Preoperative left atrial diameter 0.0312 0.1472 0.863 22.24 <.001 0.812-0.918
CI, Confidence interval; AF, atrial fibrillation.
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(2) Maze procedure ablation must be transmural, otherwise
the residual myocardial tissue can continue to conduct elec-
trical activity and form or maintain reentry loops.22 Abla-
tion lines should all be ablated at least 4 times, and the
circular ablation line around the pulmonary veins should
be ablated at least 5 times. Careful operation will not in-
crease the risk of bleeding. (3) In patients with left atrial en-
largement, the number of ablation lines should be increased,
or the atrial volume should be reduced by left atrial plica-
tion (n¼ 7), to reduce the area of each section of atrial myo-
cardium and decrease the likelihood of reentry loops. (4)
The left atrial appendage should be closed to avoid throm-
bosis (n¼ 84), which also helps to reduce the left atrial vol-
ume. Surgical closure of the left atrial appendage includes
ligation, suture of the opening from the internal aspect, or
resection and suturing. Our experience indicates that sutur-
ing of the opening from the internal aspect is adequate and
safe. (5) Maze procedure ablation of the right atrium should
be performed before crossclamping of the ascending aorta
or after release of the aortic clamp at the end of surgery to
reduce aortic crossclamping time and cardiac ischemia
time. (6) Concomitant correction of tricuspid disease should
be performed in cases with tricuspid regurgitation of at
least mild severity, tricuspid dilatation, or a poorly devel-
oped or small anterior valve leaflet. AF can aggravate tri-
cuspid regurgitation and thereby increase the incidence
of heart failure and thrombosis,23 and correction of tricus-
pid disease (tricuspid valve replacement ¼ 11, tricuspid
valvuloplasty ¼ 69) increases the success rate of BRFA
and assists the recovery of cardiac function. (7) Partial peri-
cardial adhesion (n ¼ 2) should not be a contradiction to
radiofrequency ablation. Because concomitant radiofre-
quency ablation and valve replacement surgery may be
a unique chance to radically treat AF, pericardial adhesions
should be divided if the patient’s condition permits. (8) Ad-
juvant antiarrhythmic treatment, such as amiodarone (Cor-
darone; Sanofi-Aventis, Paris, France) administration, is
important. Although recurrence of AF early after surgery
may be due to failure of tissue ablation, it may also be
due to postoperative myocardial edema and inflammatoryTABLE 4. Duration of atrial fibrillation versus left atrial diameter
Duration of AF LA 30-60 mm LA 60-80 mm LA>80 mm
6-12 mo 22 4 0
>12 mo 98 60 7
AF, Atrial fibrillation; LA, left atrium.
1016 The Journal of Thoracic and Cardiovascular Surreactions, which may cause reduction in the atrial refractory
period for 3 to 6 months.
The results of the present study indicate that the left atrial
diameter and the duration of AF may be important factors
affecting the recovery and maintenance of sinus rhythm af-
ter radiofrequency ablation.24,25 Seven patients had a left
atrial diameter of more than 80 mm before surgery, of
whom 2 maintained sinus rhythm and 5 had recurrence of
AF within 1 month after surgery. This may be because the
ablation-induced damage around the pulmonary veins ac-
counts for a smaller proportion of atrial myocardial tissue
in patients with a bigger left atrium, thereby decreasing
the likelihood of blocking the reentry loops. The ‘‘AF be-
gets AF’’ phenomenon, which describes the tendency of
AF to reinitiate itself and become repetitive or continuous,
means that the longer the duration of AF, the more stable it
becomes and the more difficult it becomes to revert to sinus
rhythm. Our observations indicate that it is easier to main-
tain sinus rhythm after radiofrequency ablation in patients
with a left atrial diameter less than 60 mm and a duration
of AF less than 36 months. A total of 120 patients
(n ¼ 116/120, 96.67%) had a left atrial dimension less
than 60 mm. A total of 64 patients (n ¼ 61/63, 96.83%)
had a duration of AF less than 36 months (Table 4). Age
is usually considered an important factor affecting the re-
currence rate of AF, but the present study did not find any
correlation between age and the effectiveness of radiofre-
quency ablation, with all 3 patients aged more than 60 years
reverting to sinus rhythm after surgery.
Three patients died of low cardiac output syndrome at 2, 3,
and 5 days after surgery, respectively. These 3 patients had
poor cardiac function before surgery, were aged more than
55 years, and had longer aortic crossclamping and cardio-
pulmonary bypass times than other patients. This suggests
that there should be strict indications for valve replacement
surgery with concomitant radiofrequency ablation to avoid
extra myocardial damage due to the prolongation of aortic
crossclamping and cardiopulmonary bypass times needed
to perform radiofrequency ablation, and to avoid subsequent
severely low cardiac output and related complications.Study Limitations
The patients did not undergo rigorous follow-up by pres-
ent standards. Few of the patients had any monitoring more
than 12-lead ECG and electrocardiogram to document their
rhythm. Furthermore, the long-term results of BRFA still re-
quire further study.gery c April 2013
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DCONCLUSIONS
Because of the multiple adverse consequences of AF, re-
covery of sinus rhythm and atrial contraction has significant
effects on the improvement of hemodynamics, cardiac func-
tion, and quality of life. When performed concomitantly
with valve replacement surgery, BRFA does not signifi-
cantly prolong aortic crossclamping or cardiopulmonary
bypass times and has minor effects on the degree of myocar-
dial ischemia and trauma, but it has a good short-term suc-
cess rate. In addition, BRFA is simple and safe, and
therefore deserves to be promoted.
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